- Home
- latamerica
- News
Refine by
Medical Industry News
9,561 news found
June 9, 2026, Austin, TX — Zetagen Therapeutics, a clinical-stage biopharmaceutical company focused on therapies for primary and metastatic breast cancer, today reported preliminary topline results from its Phase 2a open-label study evaluating ZetaMet (Zeta BC 003) in metastatic breast cancer with lytic bone lesions. The study indicates cessation of tumor activity in treated vertebral bodies and ...
Publication date: 9 June 2026. Zetagen Therapeutics announces the MBC-003 ph2a preliminary results to be featured in an ASCO abstract for 2026.About Zetagen TherapeuticsFounded in 2015, Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company dedicated to developing breakthrough therapies via local administration for metastatic and primary cancers to bone and other organs. The ...
Corify Care announced the ACORYS-AI4AF clinical trial at Mayo Clinic, initiating the first U.S. evaluation of instant Global Cardiac Mapping for atrial fibrillation (AF) treatment using the ACORYS system. The study will assess how the 4D FAST-MAP technology supports clinical decision-making in AF ablation.The trial will determine whether ACORYS can identify patients likely to benefit from ...
Guardant Health announces that a blood-based colorectal cancer screening option has been added by a cancer group, expanding noninvasive screening pathways for eligible individuals.The cancer group now lists a blood test as an additional colorectal cancer screening option, reflecting a shift toward noninvasive screening modalities.Clinicians and healthcare systems may experience implications for ...
Guardant Health today announced that blood-based testing is now included in official screening recommendations for colon and rectal cancer.Original: ...
SHANGHAI, May 25, 2026 – Huateng Pharma will present its catalog of polyethylene glycol (PEG) derivatives and custom manufacturing services at CPHI China 2026. The technical and business development teams will be available at Booth W3P16 from June 16 to June 18 at the Shanghai New International Expo Center. As a global supplier supporting pharmaceutical and chemical development, Huateng ...
Guardant Health announced that the U.S. Food and Drug Administration has approved an updated liquid biopsy assay.Original: ...
Each May, communities across the United States and its territories observe Asthma and Allergy Awareness Month to promote education, prevention, and effective management of respiratory conditions. This year, the global observance included World Asthma Day on May 5, reinforcing the importance of reducing exposure to asthma triggers and improving air quality in everyday environments. Asthma ...
BC Platforms has partnered with Flower Labs to enable federated machine learning within BC Mosaic, its trusted research environments (TREs), to support secure AI development across distributed clinical, real-world, and multi-modal data.The Flower Framework, an open-source federated learning framework from Flower Labs, is integrated to enable organizations to deploy and run machine learning across ...
Bremen, Germany – May 4, 2026 — Kerecis, the company pioneering the use of sustainably sourced intact fish skin in cellular therapy and tissue regeneration, will play a prominent scientific and educational role at EWMA-DEWU 2026 Conference, taking place May 6–8 at the Messe & Congress Centrum Bremen in Bremen, Germany.This year EWMA, The European Wound Management Association meeting, is held in ...
ByKerecis
The U.S. House Appropriations Committee’s Fiscal Year 2027 Military Construction and Veterans Affairs (MilCon/VA) appropriations report highlights the role of regenerative wound technologies, including fish-skin-derived products, in limb preservation and value-driven care within the Veterans Health Administration (VHA).The report acknowledges the ongoing burden of chronic, complex, and ...
ByKerecis
Carrying out renovation or construction work in a functioning hospital is an extremely complex and high-risk undertaking. Beyond the inconvenience caused by noise or the rearrangement of spaces, the main threat lies in the dust generated. This dust is not mere dirt; it is a potent vector for the transmission of pathogens, particularly fungal spores such as Aspergillus, a microorganism ubiquitous ...
ByEnvira
In an in vitro fertilisation (IVF) laboratory, every detail counts. The success of the process, from the fertilisation of the egg to the development of the embryo, depends on exceptionally rigorous environmental control. Temperature, humidity and light are monitored with pinpoint accuracy. However, there is an invisible factor that can compromise the entire procedure and which has been revealed ...
ByEnvira
Hospitals are, by definition, places of healing. Paradoxically, however, they can also be sources of infections contracted during a patient’s stay in hospital, known as nosocomial infections or healthcare-associated infections (HAIs). These infections represent a serious global public health problem, causing increased patient morbidity and mortality, prolonging hospital stays and driving up ...
ByEnvira
Not all hospital-acquired infections are transmitted by contact. A significant number of them—and often the most difficult to control—originate in the air we breathe. Pathogens responsible for diseases such as tuberculosis, legionellosis or fungal infections such as Aspergillus are spread via bioaerosols: tiny particles of biological origin that can remain suspended in the air for ...
ByEnvira
Corify Care today announced a clinical milestone with two studies published in Heart Rhythm and Europace, validating its 4-D global cardiac mapping technology for atrial and ventricular arrhythmias in a single beat.Compared with conventional mapping, which often requires rhythm induction or dependence on pre-procedural imaging, the ACORYS mapping system captures global cardiac electrical activity ...
MADRID, Spain – April, 2026 — Corify Care today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the ACORYS® System, the first imageless, non-invasive cardiac mapping platform capable of delivering a global, four-chamber view of cardiac electrical activity in real time.The milestone represents a fundamental shift in electrophysiology by combining ...
Orlando, FL – April 16, 2026 – Kerecis, a developer of fish-skin-based tissue regeneration products, reported new clinical data at the American Burn Association Annual Meeting indicating that intact fish-skin grafts reduce hospital length of stay for severely burned patients requiring skin grafting.The study is retrospective and propensity-matched, examining de-identified data from the American ...
ByKerecis
Charlotte, North Carolina – April 7, 2026. Kerecis will highlight its intact fish-skin platform and new clinical data at SAWC Spring 2026, taking place April 8–11 at the Charlotte Convention Center. The company will showcase intact fish-skin grafts alongside Biatain wound dressings and discuss expanded multi-specialty adoption. Booth presence is at Booth 1508; clinical insights and trial results ...
ByKerecis
MADRID, Spain – March 2026 – Corify Care announces ATENEA, a project introducing real-time Digital Twin technology to the electrophysiology laboratory, enabling clinicians to simulate and optimize ablation strategies before intervention.ATENEA represents Phase 2 of the Corify platform, focusing on AI-driven Digital Twin development to assist electrophysiologists in diagnosing and treating complex ...